Sage Journals: Discover world-class research

Free access

Research article

First published 2012-1

Tesaglitazar,a Dual PPAR-α/γ Agonist,Hamster Carcinogenicity,Investigative Animal and Clinical Studies

Per Lindblom, Anna-Lena Berg, Hui Zhang [...]

Toxicologic Pathology

Free access

Research article

First published 2007-09

A double-blind,randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitus

Harold Bays, Jennifer McElhattan, Brian S Bryzinski

Diabetes & Vascular Disease Research

Free access

Research article

First published 2011-2

Proliferative and Molecular Effects of the Dual PPARα/γ Agonist Tesaglitazar in Rat Adipose Tissues: Relevance for Induction of Fibrosarcoma

Björn Glinghammar, Anna-Lena Berg, Sivert Bjurström [...]

Toxicologic Pathology

Free access

Research article

First published 2007-09

Efficacy,safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes

Robert E Ratner, Shamik Parikh, Conrad Tou

Diabetes & Vascular Disease Research

Free access

Research article

First published 2007-09

Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPARα/γ agonist,tesaglitazar

Bjorn Fagerberg, Herbert Schuster, Grethe Støa Birketvedt [...]

Diabetes & Vascular Disease Research

Free access

Research article

First published 2007-09

The effects of tesaglitazar as add-on treatment to metformin in patients with poorly controlled type 2 diabetes

Burkhard Göke, Ingrid Gause-Nilsson, Anders Persson

Diabetes & Vascular Disease Research

Free access

Research article

First published 2007-09

Tesaglitazar,as add-on therapy to sulphonylurea,dose-dependently improves glucose and lipid abnormalities in patients with type 2 diabetes

John PH Wilding, Ingrid Gause-Nilsson, Anders Persson

Diabetes & Vascular Disease Research

Retricted access

Other

First published 2006-05

Goodbye glitazars?

Deane Conlon

The British Journal of Diabetes & Vascular Disease

Free access

Editorial

First published 2007-09

Learning from tesaglitazar

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2007-6

Evolution of Peroxisome Proliferator-Activated Receptor Agonists

Feng Chang, Linda A Jaber, Helen D Berlie [...]

Annals of Pharmacotherapy

Search results